Cancer Center at Saint Joseph's — Phoenix, Arizona

Public research footprint of Cancer Center at Saint Joseph's, compiled from the ClinicalTrials.gov public registry.

158

Registered studies

133

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Urothelial Carcinoma · Locally Advanced Urothelial Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT02506153 — Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or… (Active Not Recruiting)
NCT02224781 — Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and… (Active Not Recruiting)
NCT03793179 — Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cancer Center at Saint Joseph's?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.